AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
SOLIFENACIN SUCCINATE in Malawi
6 products registered with PMRA — 0 active, 6 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| URYSOREN_5 5MG TABLET TABLET | PMPB/PL106/76 | — | expired | 31 Mar 2025 |
| URYSOREN_10 10MG TABLET TABLET | PMPB/PL106/75 | — | expired | 31 Mar 2025 |
| GOAB_5 5MG TABLET TABLET | PMPB/PL401/116 | — | expired | 31 Mar 2024 |
| GOAB_10 10MG TABLET TABLET | PMPB/PL401/115 | — | expired | 31 Mar 2024 |
| VESIZEN_10 10MG TABLET TABLET | PMPB/PL67/134 | — | expired | 31 Mar 2023 |
| VESIZEN_5 5MG TABLET TABLET | PMPB/PL67/135 | — | expired | 31 Mar 2023 |
SOLIFENACIN SUCCINATE — PMRA Registration Details
PMRA (Malawi) has 6 registered products containing SOLIFENACIN SUCCINATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track SOLIFENACIN SUCCINATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.